IPO Subscription and Reviews

Swastika Investmart holds a ‘Neutral’ rating on the issue. “Medi Assist concentrates a significant portion of its revenue on a limited number of clients, and its subsidiaries play a crucial role in its overall performance, introducing dependencies. Additionally, the offering is a pure OFS with a premium valuation that warrants a cautious approach,” said Shivani Nyati, Head of Wealth, Swastika Investmart.Read more:

1. Medi Assist Healthcare IPO: Should You Subscribe to Rs 1,171.58 Crore Issue? - moneycontrol.com